Our Technology

Axcynsis Discovery Platform

Antibody Discovery Technology

  • Deep understanding of the target Biology
  • Antibody discovery and engineering

“LP”
Technology

  • Proprietary Payloads with multiple mechanism of actions
  • Proprietary Linker + Payload

Conjugation
Technology

  • Enzymatic and chemical site-specific conjugation to afford homogeneous ADCs

Axcynsis Pipeline

Target Indication Discovery Optimization IND-enabling Clinical Trials
AT – 01 Undisclosed Liquid & Solid Tumours
Optimization
AT – 03 Undisclosed Solid Tumours
Discovery
AT – 04 Undisclosed Solid Tumours
Discovery
AT – 00 Undisclosed Undisclosed
Discovery